Markus Blaurock
Overview
Explore the profile of Markus Blaurock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blaurock M, Brunner C, Busch C
HNO
. 2024 Nov;
72(12):857-861.
PMID: 39499266
Background: Systemic therapy of head and neck squamous cell carcinoma (HNSCC), in contrast to local therapy, is a very general term for the use of drugs that affect the entire...
2.
Felser S, Rogahn J, Glass A, Bonke L, Struder D, Stolle J, et al.
PLoS One
. 2024 Aug;
19(8):e0301304.
PMID: 39173016
Introduction: Patients with head and neck cancer (PwHNC) benefit from targeted exercise interventions: symptom relief, compensation for dysfunction, improvement in quality of life (QoL). Data on acceptance physical interventions in...
3.
Gil O, Fenske B, Bremert T, Vollmer M, Scharf C, Busch C, et al.
Medicina (Kaunas)
. 2024 Feb;
60(2).
PMID: 38399597
: Obstructive sleep apnea (OSA) is common not only in the general population but even more so in patients with tumors of the head and neck region. Untreated, it leads...
4.
Brandt A, Schultheiss C, Klinghammer K, Schafhausen P, Busch C, Blaurock M, et al.
Front Oncol
. 2024 Feb;
14:1283266.
PMID: 38384801
Background: Globally, head and neck squamous cell carcinoma (HNSCC) is the seventh most common malignancy. Despite aggressive multimodal treatment approaches, recurrent and/or metastatic (R/M) disease develops in >50% of patients....
5.
Blaurock M, Busch C
HNO
. 2023 May;
71(7):425-430.
PMID: 37208494
Background: Liquid biopsy is a promising new diagnostic tool that is already used in clinical practice for multiple tumor entities and which also has great potential for head and neck...
6.
Brzoska T, Ittermann T, Ihler F, Koch C, Blaurock M, Bulow R, et al.
Healthcare (Basel)
. 2022 Nov;
10(11).
PMID: 36421635
Representative epidemiologic data on the average volume of the parotid gland in a large population-based MRI survey is non-existent. Within the Study of Health in Pomerania (SHIP), we examined the...
7.
Lehnert B, Herold J, Blaurock M, Busch C
Eur Arch Otorhinolaryngol
. 2022 May;
279(9):4617-4621.
PMID: 35522325
Purpose: Investigating whether the Acoustic Voice Quality Index (AVQI) and the Acoustic Breathiness Index (ABI) are valid and comparable to previous unmasked measurements if the speaker wears a surgical mask...
8.
Busch C, Hagel C, Becker B, Oetting A, Mockelmann N, Droste C, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406601
The receptor tyrosine kinase Axl is described to promote migration, metastasis and resistance against molecular targeting, radiotherapy, and chemotherapy in various tumor entities, including head and neck squamous cell carcinoma...
9.
Blaurock M, Busch C
HNO
. 2022 Mar;
70(4):265-270.
PMID: 35257190
Background: This article summarizes new findings on chemo- and targeted therapy of head and neck squamous cell carcinoma presented at the 2021 American Society of Clinical Oncology (ASCO) conference. Objective:...
10.
Kaftan H, Blaurock M, Kaftan S
Ann Otol Rhinol Laryngol
. 2015 Apr;
124(9):728-33.
PMID: 25862214
Objective: The results of a recently published micro-CT study suggested a correlation of the distance between long incus process and stapes footplate and the required prosthesis length in malleostapedotomy. The...